Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Implantica finally nabs FDA approval 8 years after EU green light for reflux implant

Implantica finally nabs FDA approval 8 years after EU green light for reflux implant

August 25, 2026Posted inMedical Technology

The FDA has signed off on Implantica’s gastroesophageal reflux disease (GERD) implant as the medtech eyes a lucrative U.S. market.

Post navigation

Previous Post
living-cellular-assemblies-offer-new-therapeutic-possibilities Living Cellular Assemblies Offer New Therapeutic Possibilities
Next Post
Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal

Recent Posts

  • Hypercontractile embryos from older female mice experience implantation failure
  • European summit plant communities show widespread thermophilization, weakly linked to climate warming
  • Scientists design tissue-specific mammalian enhancers that function in mouse embryos
  • Long-Term Ambient Air Pollution Exposure Linked to Global Cancer Burden
  • Disrupted Cellular RNA Balance Drives MDA5 Activation During Viral Infection

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top